期刊文献+

经皮选择性肝脏隔离灌注化疗的实验研究

Experimental study on percutaneous selective isolated hepatic perfusion chemotherapy
在线阅读 下载PDF
导出
摘要 目的探讨经皮选择性肝脏隔离灌注化疗的可行性及隔离效果。方法将12只猪随机分为两组:HAI组6头,进行常规经肝动脉灌注化疗;PSIHP组6头,利用介入放射学方法进行经皮选择性隔离肝脏灌注化疗结合血液灌流。化疗药物选用5-FU。分别检测肝静脉及外周血液中的血药浓度,并对肝组织行病理学检查。结果HAI组右肝静脉血和外周静脉血浓度峰值分别为(4082.530±415.213)mg/L,(1682.230±216.834)mg/L;PSIHP组右肝静脉血、外周静脉血血药浓度峰值分别为(5321.711±517.318)mg/L,(510.834±52.518)mg/L。两组间有显著性差异(P<0.01)。PSIHP组过滤后肝静脉血血药浓度峰值为(1192.063±114.864)mg/L,碳肾率过滤达到(77.6±0.9)%。PSIHP组灌注区域肝脏组织损害程度比HAI组大。结论PSIHP是一种简单有效的肝脏隔离灌注化疗技术,与常规经肝动脉灌注化疗相比,不仅可以增加局部血药浓度,更可以降低外周的血药浓度,降低毒副作用。 ObjectiveTo investigate the feasibility and isolation efficiency of percutaneous selective isolated hepatic perfusion chemotherapy(PSIHP). MethodsSix pigs underwent the procedure of routine transhepatic arterial infusion(HAI) and 6 underwent PSIHP.5-FU was used in this study. The drug(5-FU) (concentration) of blood from hepatic and systemic veins of both groups was observed. Liver tissue was (investigated) for pathologic changes. ResultsThe peak level of 5-FU concentration in blood from right (hepatic) vein and systemic vein in HAI group was(4082.530415.213)mg/L and (1682.230216.834)mg/L respectively.In PSIHP group, the peak level(5-FU) was(5321.711517.318)mg/L and(510.83452.518)mg/L, respectively.There was a statistically significant difference between HAI group an PSIHP group(P<0.01). The level of 5-FU concentration in blood from right hepatic vein of PSIHP group(postfiltration) was(1192.063114.864)mg/L and the filtration rate of charcoal (hemoperfusion) was(77.60.9%). The damage of perfused area of liver tissue was more serious in PSIHP group compared with HAI group. ConclusionsPSIHP is a simple and feasible method for isolated hepatic perfusion. Compared with HAI, PSIHP can increase the concentration level of chemotherapeutic agents in (regional) liver, and can even more markedly decrease the drug concentration in systemic circulation and (decrease) toxic side effcts.
出处 《中国普通外科杂志》 CAS CSCD 2005年第7期505-508,共4页 China Journal of General Surgery
基金 广东省深圳市科技局基金资助项目(200104087)。
关键词 肝肿瘤 实验性/药物疗法 灌注化 局部 氟尿嘧啶/治疗应用 <Keyword>Liver Neoplasms,Experimental/durg ther Perfusion,Rejional Fluorouracil/ther use
  • 相关文献

参考文献8

  • 1Creech JO, Krementz ET, Winblad JN, Chemotherapy of cancer: Regional perfusion utilizing an extracorporeal circuit[J].Ann Surg, 1958,148(2):616-632.
  • 2Ku Y, Iwasaki T, Fukomoto T, et al.Induction of long-term remission in advanced hepatocellular carcinoma with percutaneous isolated liver chemoperfusion[J].Ann Surg, 1998,227(2):519-526.
  • 3Ku Y, Tominaga M, Iwasaki T, et al.Isolated hepatic perfusion chemo-therapy for unresectable malignant hepatic tumors[J].Int J Clin Oncol, 2002,7(1):82-90.
  • 4吕新生.肝脏隔离灌注化疗治疗肝脏恶性肿瘤[J].中国普通外科杂志,1999,8(2):82-84. 被引量:3
  • 5李香兰,梁秀秀,吴玉波,高永君.5-氟脲嘧啶在荷瘤鼠血液及瘤体中的代谢分布[J].实用肿瘤学杂志,2001,15(2):95-97. 被引量:1
  • 6Ku Y, Iwasaki T, Fukomoto T, et al.Induction of long-term remission in advanced hepatocellular carcinoma with percutaneous isolated liver chemoperfusion[J].Ann Surg,1998,227(2):519-526.
  • 7Curley SA, Byrd DR, Newman RA, et al.Reduction of systemic durg exposure after hepatic arterial infusion of doxorubicin with complete hepatic venous isolation and extracorporeal che mofiltration[J].Surgery,1993,114(2):579-585.
  • 8Ku Y, Fukomoto T, Iwasaki T, et al.Single catheter technique of hepatic venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumor[J].Ann J Surg, 1997,173(2):103-109.

二级参考文献7

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部